Bahrain and Kuwait have signed a memorandum of understanding (MoU) in order to enhance health cooperation between the two countries.
The MoU aims to strengthen collaboration in preventive and curative health services, twin healthcare institutions, and unify stances on regional and international health issues.
It also covers cooperation in public health programs, combating communicable and non-communicable diseases, and sharing expertise in environmental health, climate change, and the One Health approach.
The MoU further includes cooperation in training, capacity building, and professional development of health workers, as well as the use of digital health and modern technologies.
It promotes collaboration with the Kuwait Institute for Medical Specializations, expanding training opportunities for Bahraini health professionals, and cooperation in telemedicine, health insurance systems, and comprehensive healthcare. It also supports school health development and pharmaceutical cooperation to ensure drug security.
The Memorandum of Understanding (MoU) was signed on the sidelines of the 11th meeting of the Health Ministers of the Gulf Cooperation Council (GCC) countries, held in conjunction with the 88th (50th session) meeting of the GCC Health Ministers’ Council.
During the event, Dr. Jaleela bint Al Sayed Jawad Hasan, Bahrain’s Minister of Health, held a meeting with Dr. Ahmad Al Awadhi, Minister of Health of the State of Kuwait.
Bahrain-Kuwait Relations
The meeting underscored the deep relations between the Kingdom of Bahrain and the State of Kuwait, and the growing cooperation across various domains, particularly in the health sector, in a way that serves shared interests and supports Gulf health integration.
The two sides discussed means to further develop bilateral health cooperation through the exchange of expertise and best practices in areas such as primary healthcare, disease prevention, and strengthening public health systems. They also discussed cooperation opportunities in health training, capacity development, and expanding partnerships in pharmaceuticals and medical technologies.
